Tru Independence LLC Novartis Ag Transaction History

Tru Independence LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 20, 2021	SELL	$83.5 - $98.47 $139,862 - $164,937	-1,675 Closed	0 $0
Q4 2020 Mar 09, 2021	BUY	$78.07 - $94.43 $4,137 - $5,004	53 Added 3.27%	1,675 $158,000
Q3 2020 Nov 19, 2020	SELL	$82.14 - $91.0 $32,363 - $35,854	-394 Reduced 19.54%	1,622 $141,000
Q2 2020 Aug 19, 2020	SELL	$80.93 - $91.1 $6,069 - $6,832	-75 Reduced 3.59%	2,016 $176,000
Q4 2019 May 19, 2020	BUY	$84.35 - $95.37 $176,375 - $199,418	2,091 New	2,091 $172,000

1,462

132M

1.33M

1.54M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $227B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Tru Independence LLC, based on Form 13F filings with the SEC.

Stay updated on Tru Independence LLC with notifications on news.